Peter Vis
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Tuberculosis Research and Epidemiology
Papers in
-
- Pharmacological Effects and Toxicity Studies 6
- Neonatal and fetal brain pathology 2
-
- HIV/AIDS drug development and treatment 8
- Tuberculosis Research and Epidemiology 2
- Co-authors
- Jos Delbeke (3 shared papers)Sarah McLeay (2 shared papers)Bruce Green (2 shared papers)Rolf P. G. van Heeswijk (1 shared paper)Thomas N. Kakuda (4 shared papers)Vanitha Sekar (2 shared papers)Anita Shah (2 shared papers)Meindert Danhof (2 shared papers)
- Journals
- Journal of the International AIDS Society (2 papers)Investigative Radiology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Hepatology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesNetherlandsBelgium
In The Last Decade
Peter Vis
23 papers receiving 359 citations
Peers
Comparison fields: 5 of 90
- Virology 87
- Infectious Diseases 204
- General Energy 4
- Hematology 42
- Pediatrics, Perinatology and Child Health 72
Countries citing papers authored by Peter Vis
This map shows the geographic impact of Peter Vis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vis more than expected).
Fields of papers citing papers by Peter Vis
This network shows the impact of papers produced by Peter Vis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vis. The network helps show where Peter Vis may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Vis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 56 | |
| 2 | 2019 | 46 | |
| 3 | 2009 | 37 | |
| 4 | 2010 | 37 | |
| 5 | 2017 | 32 | |
| 6 | 2012 | 28 | |
| 7 | 1994 | 23 | |
| 8 | 2010 | 19 | |
| 9 | 2019 | 13 | |
| 10 | 2016 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2010 | 11 | |
| 13 | 2015 | 10 | |
| 14 | 2001 | 8 | |
| 15 | 2020 | 8 | |
| 16 | 2010 | 4 | |
| 17 | 2016 | 4 | |
| 18 | 2013 | 3 | |
| 19 | 1992 | 2 | |
| 20 | 2020 | 2 |
About Peter Vis
Peter Vis is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases, Virology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 27 papers that have together received 371 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Neonatal Respiratory Health Research (3 papers), Hemophilia Treatment and Research (2 papers), Neonatal and fetal brain pathology (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Tuberculosis Research and Epidemiology (2 papers). The work is most often cited by research in Virology (87 citations), Infectious Diseases (204 citations), General Energy (4 citations), Hematology (42 citations) and Pediatrics, Perinatology and Child Health (72 citations). Peter Vis has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Jos Delbeke, Sarah McLeay, Bruce Green, Rolf P. G. van Heeswijk, Thomas N. Kakuda, Vanitha Sekar, Anita Shah, Meindert Danhof, Dirk Garmann and Rob A. Voskuyl. Their work appears in journals such as Journal of the International AIDS Society, Investigative Radiology, Journal of Pharmacology and Experimental Therapeutics, Journal of Hepatology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.